Ferrosan Medical Devices
PrivateLast Round
Buyout/LBO
Sep 27, 2022
Est. Valuation
$644.5M
Momentum Score
25 /100
Company Overview
Ferrosan Medical Devices is a surgical devices company that develops and manufactures products for hemostasis during surgery and handheld biopsy devices for cancer diagnostics.
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ferrosan Medical Devices Comps
Public and private peers based on sector, stage, and business model.
Ferrosan Medical Devices Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Sep 27, 2022 | ||||
| Private Equity | Jul 7, 2017 | ||||
| Buyout/LBO | Dec 1, 2011 |
Key People
Founding team and executive leadership
Ferrosan Medical Devices Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Buyout/LBO |
| Kirk Kapital | Private Equity, Buyout/LBO |
| Impilo | Private Equity |
| ATP | Buyout/LBO |
| Altor Equity Partners | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors grew 384% MoM to 1.8K.
- Sep 27, 2022
$645M round led by Kirk Kapital
Ferrosan Medical Devices Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ferrosan Medical Devices's valuation, stock price, and market status.
